Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07126613 · ClinicalTrials.gov registry record · NA

Mobile Alcohol Use Intervention

A NA study of Alcohol Misuse, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07126613: Completed NA study of Alcohol Misuse, sponsored by University of North Carolina, Chapel Hill.

NCT07126613 is a NA study of Alcohol Misuse that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 40 participants, below the 1,619-participant average among 8 other Alcohol Misuse trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07126613, a NA study of Alcohol Misuse, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study aims to examine the feasibility and acceptability of a mobile health intervention to reduce alcohol use and related consequences among young adults. Participants will be randomly assigned to either receive access to the mobile health intervention or receive only generic study surveys. Participants will receive text message surveys sent to their personal cellphone for 4 weeks per their assigned trial arm. All participants will receive a post-survey 30 days after their final weekly survey text.

Primary Outcome

Measured using the following item, "How satisfied are you with your experience using this intervention?" with a 5-point response scale ranging from Not at All Satisfied (1) to Extremely Satisfied (5). A higher score indicates higher satisfaction with the intervention

Conditions Studied

Interventions

  • BEHAVIORAL Mobile Health Intervention to Reduce Alcohol Use Among Young Adults

Study Locations (1)

North Carolina

  • Rosenau Hall - Chapel Hill

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-09-29
Est. Completion 2026-01-06
Phase NA

What the finished NCT07126613 record still lists

NCT07126613 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,619-participant average among 8 other Alcohol Misuse trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Alcohol Misuse appearing as the primary indexed condition, and to 1 intervention - of which Mobile Health Intervention to Reduce Alcohol Use Among Young Adults is the first listed.

NCT07126613 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07126613 about?

NCT07126613 is a clinical study titled "Mobile Alcohol Use Intervention". This study aims to examine the feasibility and acceptability of a mobile health intervention to reduce alcohol use and related consequences among young adults. Participants will be randomly assigned to either receive access to the mobile health intervention or receive only generic study surveys. Par...

What is the current status of trial NCT07126613?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-29. Estimated completion is 2026-01-06.

What conditions does trial NCT07126613 study?

This clinical trial studies the following conditions: Alcohol Misuse.

What interventions are being tested in trial NCT07126613?

The interventions under investigation include: Mobile Health Intervention to Reduce Alcohol Use Among Young Adults (BEHAVIORAL).

Who is sponsoring clinical trial NCT07126613?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07126613 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Misuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07126613's enrollment target sits among peer trials

40 6th of 8 higher than 2 of 8 other Alcohol Misuse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Misuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07126613, the US trial registry maintained by the National Library of Medicine. NCT07126613 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.